Keyphrases
United States
100%
Randomized Placebo-controlled Trial
100%
Twice Daily
100%
Once-daily
100%
Budesonide
100%
Active Crohn's Disease
100%
Divided Dose
100%
Placebo
66%
Crohn's Disease
66%
Crohn's Disease Activity Index
66%
Remission Rate
50%
Remission
33%
Treatment Group
33%
Distal Ileum
33%
Moderate to Severe
16%
Adverse Events
16%
Change in Mean
16%
Disease Remission
16%
Placebo Groups
16%
Double-blind Randomized Trial
16%
Difference in Mean
16%
Placebo Response
16%
Cortisol Level
16%
Combined Treatment
16%
Change from Baseline
16%
Ascending Colon
16%
Plasma Cortisol
16%
Proximal Colon
16%
Systemic Activity
16%
Safe Rates
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo-Controlled Study
100%
Budesonide
100%
Crohn's Disease
100%
Placebo
66%
Remission
66%
Disease Activity
44%
Ileum
22%
Adverse Event
11%
Glucocorticoid
11%
Hydrocortisone
11%
Ascending Colon
11%
Agricultural and Biological Sciences